Tag: biogen

January 26, 2021

Top Life Science ETFs of 2020

What are the top life science ETFs? Here's a look at the five best-performing life science ETFs of 2020.
September 28, 2020

What is In-Licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
February 27, 2020

Barclays Sees Upside in US Biopharma Industry

Barclays Capital has initiated coverage of the US biopharma space and will follow 16 companies in the market.
April 16, 2019

Biotech Market Update: Q1 2019 in Review

With Q1 2019 officially over, the Investing News Network shares a biotech market update on the biggest news and trends...
January 4, 2019

Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers

Biogen (Nasdaq:BIIB) and Skyhawk Therapeutics announced a strategic collaboration in which the companies will leverage Skyhawk’s SkySTAR™ technology platform with the...
November 1, 2018

VIDEO — Life Science Update October 2018

With October behind us, the Investing News Network (INN) has brought together some of the biggest stories in the life...
October 24, 2018

Forward Pharma Loses Patent Appeal Trial

The appeal was against Biogen’s drug Tecfidera. Forward will lose out on future royalty payments for Biogen’s commercial product in...